Related Experiment Video
Updated: May 17, 2026
Immunohistochemical Staining of B7-H1 (PD-L1) on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
Functional analysis of B7-H3 in colonic carcinoma cells
1Department of Oncological Surgery, People's Hospital of Zhengzhou, Zhengzhou, China.
Abstract:
B7-H3 is a newly discovered member of the B7/CD28 superfamily which functions as an important T-cell immune molecule. It has been reported recently that B7-H3 is highly expressed in many cancer cells, the data indicating that it may be a regulation factor contributing to tumor-resistance. In our study, we used bioinformatics to identify differentially expressed genes between colonic cancer cells and normal colonic cells, aiming to analyze mechanisms and identify sub-pathways closely related to progression, with the final aim of finding small molecule drugs which might interfere this progression. We found that ajmaline is one related factor which may enhance self-immunity in colon carcinoma therapy and B7-H3 plays important roles with regard to immunoreactions of colonic cancer cells. All the results indicate that H7-B3 is a favorable prognostic biomarker for colon carcinomas, providing novel information regarding likely targets for intervention.
Insights
B7-H3, a T-cell immune molecule, is highly expressed in colon cancer. This study found B7-H3 is a prognostic biomarker and ajmaline may enhance immunotherapy for colon carcinomas.
Area of Science:
- Immunology
- Oncology
- Bioinformatics
Background:
- B7-H3 is a T-cell immune molecule.
- B7-H3 is highly expressed in many cancer cells, suggesting a role in tumor resistance.
- Colon cancer progression involves complex molecular mechanisms.
Purpose of the Study:
- To identify differentially expressed genes in colon cancer cells using bioinformatics.
- To analyze mechanisms and sub-pathways related to colon cancer progression.
- To find potential small molecule drugs targeting colon cancer progression.
Main Methods:
- Bioinformatic analysis of gene expression data.
- Comparison between colon cancer cells and normal colonic cells.
- Identification of key molecular targets and pathways.
Main Results:
- Ajmaline identified as a factor potentially enhancing anti-tumor immunity in colon carcinoma.
- B7-H3 plays a significant role in the immunoreactions of colon cancer cells.
- B7-H3 identified as a favorable prognostic biomarker for colon carcinomas.
Conclusions:
- B7-H3 is a promising prognostic biomarker for colon cancer.
- Understanding B7-H3's role in immunoreactions offers novel therapeutic intervention targets.
- Ajmaline may be a potential therapeutic agent for enhancing colon cancer immunotherapy.
